Literature DB >> 19617664

Changes in plasma concentrations of hypoxanthine and uric acid before and after hemodialysis.

Heshmatollah Shahbazian1, Ahmad Zand Moghadam, Ali Ehsanpour, Mahyar Khazaali.   

Abstract

INTRODUCTION: Purine metabolites constitute a major class of uremic toxins, and reliable characterization of which helps nephrologists to choose the most appropriate treatment for the patients individually. In the present study, we assessed plasma concentrations of hypoxanthine and uric acid as purine metabolites in patients on maintenance hemodialysis, before and after a dialysis session.
MATERIALS AND METHODS: A total of 20 patients on maintenance hemodialysis were enrolled in this study. All of the patients underwent a routine 4-hour dialysis, as scheduled 3 times per week. Polysulfone membranes and bicarbonate dialysis solution were used in all dialysis sessions. Blood specimens were taken from the arteriovenous fistula immediately before and after one hemodialysis session, in order to measure plasma concentrations of hypoxanthine and uric acid by high-performance liquid chromatography, and to compare the predialysis and postdialysis values.
RESULTS: Before hemodialysis, the mean plasma hypoxanthine and uric acid concentrations were 18.93 +/- 8.28 micromol/L and 44.16 +/- 22.88 micromol/L, respectively. After hemodialysis, these concentrations reduced to 13.68 +/- 4.42 micromol/L and 15.61 +/- 11.12 micromol/L, respectively. Hypoxanthine concentration had a 27.7% decrease after hemodialysis (mean difference, 5.25 +/- 6.24 micromol/L; 95% confidence interval, 2.32 to 8.10; P < .001). Also, uric acid concentration decreased by 64.6% (mean difference, 28.55 +/- 14.39 micromol/L; 95% confidence interval, 21.81 to 32.28; P < .001).
CONCLUSIONS: Plasma concentrations of hypoxanthine and uric acid are higher than normal before hemodialysis, and they decrease significantly after hemodialysis; however, both of them may be still higher than normal values.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19617664

Source DB:  PubMed          Journal:  Iran J Kidney Dis        ISSN: 1735-8582            Impact factor:   0.892


  5 in total

Review 1.  Normal and pathologic concentrations of uremic toxins.

Authors:  Flore Duranton; Gerald Cohen; Rita De Smet; Mariano Rodriguez; Joachim Jankowski; Raymond Vanholder; Angel Argiles
Journal:  J Am Soc Nephrol       Date:  2012-05-24       Impact factor: 10.121

2.  The 3-Year Incidence of Gout in Elderly Patients with CKD.

Authors:  Vivian S Tan; Amit X Garg; Eric McArthur; Ngan N Lam; Manish M Sood; Kyla L Naylor
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-02       Impact factor: 8.237

3.  Hypoxanthine induces cholesterol accumulation and incites atherosclerosis in apolipoprotein E-deficient mice and cells.

Authors:  Hye-Myung Ryu; You-Jin Kim; Eun-Joo Oh; Se-Hyun Oh; Ji-Young Choi; Jang-Hee Cho; Chan-Duck Kim; Sun-Hee Park; Yong-Lim Kim
Journal:  J Cell Mol Med       Date:  2016-07-11       Impact factor: 5.310

4.  Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis.

Authors:  Zhi-Hao Zhang; Feng Wei; Nosratola D Vaziri; Xian-Long Cheng; Xu Bai; Rui-Chao Lin; Ying-Yong Zhao
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

5.  Rhubarb Protect Against Tubulointerstitial Fibrosis by Inhibiting TGF-β/Smad Pathway and Improving Abnormal Metabolome in Chronic Kidney Disease.

Authors:  Zhi-Hao Zhang; Ming-Hua Li; Dan Liu; Hua Chen; Dan-Qian Chen; Ning-Hua Tan; Shuang-Cheng Ma; Ying-Yong Zhao
Journal:  Front Pharmacol       Date:  2018-09-13       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.